The development of neutralizing antibodies against SARS-CoV-2 and their common features

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide severe coronavirus disease 2019 (COVID-19) pandemic since December 2019. There is a great demand for effective therapies for the prevention and treatment of COVID-19. Developing therapeutic neutralizing antibodies (N...

Full description

Saved in:
Bibliographic Details
Published in:J Mol Cell Biol
Main Authors: Liu, Liu Daisy, Lian, Chaoyang, Yeap, Leng-Siew, Meng, Fei-Long
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Reviews
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7799018/
https://ncbi.nlm.nih.gov/pubmed/33377928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jmcb/mjaa070
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items